WORKING GROUP NAME: CTD-ILD

Interstitial lung diseases (ILD), including those related to connective tissue disease (CTD), and
idiopathic pulmonary fibrosis (IPF) carry high morbidity and mortality. Great efforts are under way
to develop and investigate meaningful treatments in the context of clinical trials. However, efforts
have been challenged by a lack of validated outcome measures and by inconsistent use of measures
in clinical trials.

Screen Shot 2020-09-30 at 12.36.56 PM

RECENT PUBLICATIONS

CO-CHAIRS

Screen Shot 2020-09-30 at 12.44.13 PM

Dinesh Khanna:

khannad@umich.edu

Screen Shot 2020-09-27 at 7.49.20 AM

Susanna Proudman:

sproudman@internode.on.net


Athol Wells:

Athol.Wells@rbht.nhs.uk

Alexa Meara

FELLOW

Screen Shot 2020-09-30 at 12.47.01 PM

MEMBERSHIP:

Rothit Aggarwal
Shaney Barratt
Elana Bernstein
Kevin Brown
Nicola Dalbeth
Mackenzie Dubois

Kevin Flaherty
Dinesh Khanna
Eric Matteson
Shikha Mittoo
Susanna Proudman
David Roofeh

Vivek Nagaraja
Leslie Saketkoo
James Seibold
Vibeke Strand
Athol Wells
Peter Tugwell